EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Adeno-Associated Virus Vectors: Principles, Practices, and Prospects in Gene Therapy

Limor Zwi-Dantsis iD, Saira Mohamed, Giulia Massaro iD, Emad Moeendarbary iD

Viruses · 09.02.2025 · 17 (2) · 239

DOI: 10.3390/v17020239 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 09.02.2025. Verfasst von Limor Zwi-Dantsis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical Engineering, Roberts Building, University College London, London WC1E 6BT, UK. Hauptthemen laut MEDLINE: Dependovirus, Genetic Therapy, Genetic Vectors. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 209 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BBSRC, EPSRC, Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gene therapy offers promising potential as an efficacious and long-lasting therapeutic option for genetic conditions, by correcting defective mutations using engineered vectors to deliver genetic material to host cells. Among these vectors, adeno-associated viruses (AAVs) stand out for their efficiency, versatility, and safety, making them one of the leading platforms in gene therapy. The enormous potential of AAVs has been demonstrated through their use in over 225 clinical trials and the FDA’s approval of six AAV-based gene therapy products, positioning these vectors at the forefront of the field. This review highlights the evolution and current applications of AAVs in gene therapy, focusing on their clinical successes, ongoing developments, and the manufacturing processes required for the rapid commercial growth anticipated in the AAV therapy market. It also discusses the broader implications of these advancements for future therapeutic strategies targeting more complex and multi-systemic conditions and biological processes such as aging. Finally, we explore some of the major challenges currently confronting the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusGenetic TherapyGenetic VectorsHumansAnimalsClinical Trials as Topic

Stichwörter der Autor:innen

adeno-associated virus (AAV)clinical trialsgene therapyvector manufacturing

Autor:innen und Institutionen

  • Department of Mechanical Engineering, Roberts Building, University College London, London WC1E 6BT, UK.
  • UCL School of Pharmacy, University College London, London WC1N 1AX, UK.

ORCID-Profile: Limor Zwi-Dantsis, Giulia Massaro, Emad Moeendarbary

Förderung

  • BBSRC
  • EPSRC
  • Biotechnology and Biological Sciences Research Council
  • Cancer Research UK
  • Cancer Research UK Multidisciplinary Award
  • Animal Free Research UK

Zitieren

APA

Zwi-Dantsis, L., Mohamed, S., Massaro, G., & Moeendarbary, E. (2025). Adeno-Associated Virus Vectors: Principles, Practices, and Prospects in Gene Therapy. Viruses, 17(2), 239. https://doi.org/10.3390/v17020239

Vancouver

Zwi-Dantsis L, Mohamed S, Massaro G, Moeendarbary E. Adeno-Associated Virus Vectors: Principles, Practices, and Prospects in Gene Therapy. Viruses. 2025;17(2):239. doi:10.3390/v17020239

BibTeX
@article{ZwiDantsis2025,
  author = {Zwi-Dantsis, Limor and Mohamed, Saira and Massaro, Giulia and Moeendarbary, Emad},
  title = {Adeno-Associated Virus Vectors: Principles, Practices, and Prospects in Gene Therapy},
  journal = {Viruses},
  year = {2025},
  volume = {17},
  number = {2},
  pages = {239},
  doi = {10.3390/v17020239}
}
Kostenlos starten →